Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3

NCT: NCT07712172 · COMPLETED

NCT IDNCT07712172
StatusCOMPLETED
Start Date2025-01-01
Completion2026-05-30
SponsorPost Graduate Institute of Medical Education and Research, Chandigarh (OTHER)
First posted
Last updated

Brief Summary

The goal of this observational study is to quantify activity and extent of disease in patients with GPA using 18F-FDG PET/CT. The main questions it aims to answer are: Sensitivity of 18 F-FDG PET/CT in patients with GPA? Correlation of 18F-FDG PET/CT semi-quantitative parameters with BVAS v3?

Frequently Asked Questions

What is Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3?

Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3 is a clinical trial registered under NCT07712172. Current status: COMPLETED.

What is the status of NCT07712172?

The current status of NCT07712172 (Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3) is: COMPLETED.

When did Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3 start?

Assessing Granulomatosis With Polyangiitis Activity: 18F-FDG PET/CT vs BVAS v3 started on 2025-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑